Global Biopharmaceutical CDMO Supply, Demand and Key Producers, 2023-2029

Global Biopharmaceutical CDMO Supply, Demand and Key Producers, 2023-2029

The global Biopharmaceutical CDMO market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Biopharmaceutical CDMO demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Biopharmaceutical CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biopharmaceutical CDMO that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Biopharmaceutical CDMO total market, 2018-2029, (USD Million)

Global Biopharmaceutical CDMO total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Biopharmaceutical CDMO total market, key domestic companies and share, (USD Million)

Global Biopharmaceutical CDMO revenue by player and market share 2018-2023, (USD Million)

Global Biopharmaceutical CDMO total market by Type, CAGR, 2018-2029, (USD Million)

Global Biopharmaceutical CDMO total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Biopharmaceutical CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, WuXi AppTec, Catalent, Thermo Fisher, Recipharm, Samsung Biologics, Siegfried, Delpharm and Boehringer Ingelheim, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biopharmaceutical CDMO market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Biopharmaceutical CDMO Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Biopharmaceutical CDMO Market, Segmentation by Type
Development and Manufacturing CDMOs
Clinical Trial Material CDMOs
Fill-Finish CDMOs
Other

Global Biopharmaceutical CDMO Market, Segmentation by Application
Pharmaceutical Company
Biotechnology Company
Other

Companies Profiled:
Lonza
WuXi AppTec
Catalent
Thermo Fisher
Recipharm
Samsung Biologics
Siegfried
Delpharm
Boehringer Ingelheim
Aenova Group
AGC Parma Chemicals
GenScript
ProBioGen
KBI Biopharma
3P Biopharmaceuticals
Rentschler Biopharma
Northway Biotech

Key Questions Answered

1. How big is the global Biopharmaceutical CDMO market?

2. What is the demand of the global Biopharmaceutical CDMO market?

3. What is the year over year growth of the global Biopharmaceutical CDMO market?

4. What is the total value of the global Biopharmaceutical CDMO market?

5. Who are the major players in the global Biopharmaceutical CDMO market?